Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label MedRhythms. Show all posts
Showing posts with label MedRhythms. Show all posts

Monday, October 11, 2021

Can Music Rehabilitate Stroke Victims? Universal Music Group Thinks So

 But I bet your doctor doesn't think so having done nothing for over a decade.

Can Music Rehabilitate Stroke Victims? Universal Music Group Thinks So

Music has long been touted for its abilities to heal, whether it be helping cope with loss or evoking old memories. Now, one ambitious medical startup — with the endorsement of the world’s largest music company — is looking to use music for a much more clinical purpose: teaching people to walk again. 

MedRhythms is a Portland, Maine-based medical startup founded in 2015 that combines music and health care technology to help patients with neurological injuries and diseases improve their ability to walk. It’s fast-growing, having closed a $25 million funding round in July, and its tech has gone through trials at major hospitals across the country, including Cleveland Clinic, Johns Hopkins and Massachusetts General Hospital. Now MedRhythms has closed on another crucial partnership, a licensing deal with Universal Music Group that gives the company’s platform and its patient base access to one of the deepest catalogs in music. 

“Everybody can relate to the fact that music evokes emotions and memories, and that’s the social science of music, but what MedRhythms is doing is shifting that paradigm to look at music purely through the lens of neuroscience,” says MedRhythms co-founder and CEO Brian Harris. “Music has a profound impact on our brains, objectively. Regardless of age, culture, ability or disability, almost everybody’s brain responds the same way to music. At a high level, when we as humans are passively listening to music that we like, it engages parts of our brain responsible for movement, language, and attention. There’s no other stimulus on Earth that engages our brain like music does.”

The basis of MedRhythms’ research comes from what’s called auditory motor entrainment, a subconscious link between a person’s auditory and motor systems. The average person displays such a link when they nod their head or tap their foot to the beat of a song. Those with neurological injuries or diseases like strokes or Parkinson’s disease often have a damaged motor system, but because of the link with the auditory system, Harris says, music works as a strong external stimulus to activate the motor system more effectively once again. The process could aid in neuroplasticity, the process that allows our brains to adapt and learn even as we grow older. 

During a session, MedRhythms patients hook up sensors to their shoes and listen to music through an app with headphones while the program tracks patients’ gait and lets algorithms change the music according to rhythm. Patients walk to the music, which speeds up or slows down accordingly. 

Success through MedRhythms is far from surefire — patients need some level of walkability in the first place, and there’s no guarantee on how effective the therapy is on any one person — but the results so far have been compelling. Patients have seen notable improvement after MedRhythms’ intervention, with Harris seeing the most notable success for stroke victims. One super-responder began seeing significant gait improvement as late as 20 years after suffering a stroke. MedRhythms’ research eventually led to the company’s products earning breakthrough-device status from the U.S. Food and Drug Administration.

The partnership MedRhythms has with UMG is unique in the music business. Because the music in MedRhythms’ platform will be used for strictly medical purposes, the two companies had to develop what UMG is calling a first-of-its-kind sort of prescription-music license, one that complies with the FDA.

 

Tuesday, June 16, 2020

Startup using music to help stroke patients walk gets breakthrough designation

Interesting that the FDA considers that no alternative exists. metronome (10 posts)? Headphones maybe? Yes, this is an unmet need because your doctors and stroke hospital have been failing for years to put together a music protocol. Which is a complete indictment of your stroke hospital if they won't do a damn thing for stroke until FDA approval.

 

Startup using music to help stroke patients walk gets breakthrough designation






MedRhythms, a digital health startup using sensors and music for post-stroke walking rehabilitation, received an FDA Breakthrough Device Designation.



After seeing music help his patients, Brian Harris, a board-certified music therapist, turned his work into a digital therapeutic. Called MedRhythms, the Portland-based startup uses music in conjunction with sensors to help chronic stroke patients improve their walking.
The company made an important step toward bringing its first product to market: It received the FDA’s Breakthrough Device Designation, which can accelerate the regulatory process for medical devices. To qualify, companies must prove that no alternative exists and that it addresses a significant unmet need.

“There is currently no standard of care for chronic stroke survivors with walking deficits, yet these impairments are strongly linked to fall risk, lack of independence, and decreased quality of life. We are thrilled the FDA has designated our product as a Breakthrough Device, recognizing its potential to impact an area of high unmet need and bringing us one step closer to reaching people who need this care,” Harris, CEO and co-founder of MedRhythms, said in a news release.
Danielle Briggeman, the company’s clinical and regulatory affairs manager, said she was hopeful that the designation would allow MedRhythms to bring its first product to market with an expedited timeline.
“Having this designation opens the door for swift, interactive discussions with FDA on our development efforts that we otherwise would not have under the current Pre-Submission Program,” she said in a news release.
MedRhythms developed sensors that patients can attach to their shoes. After calculating their current stride, the system begins playing music through headphones. It can change the tempo of the music so they can improve the speed of their walking.

MedRhythms is currently testing the system in a randomized clinical trial between five rehabilitation hospitals and research centers, including the Ryan AbilityLab in Chicago, the Kessler Foundation in New Jersey, Mt. Sinai Hospital in New York, Spaulding Rehabilitation Hospital in Boston, and the Boston University Neuromotor Recovery Laboratory. It will evaluate the system’s impact on walking among stroke survivors with post-stroke walking impairments.
In the future, MedRhythms plans to develop additional products for Parkinson’s disease, multiple sclerosis, aging and fall prevention.